Intrathecal antitoxin in the treatment of tetanus
Autor(a) principal: | |
---|---|
Data de Publicação: | 1987 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista do Instituto de Medicina Tropical de São Paulo |
Texto Completo: | https://www.revistas.usp.br/rimtsp/article/view/28529 |
Resumo: | Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit. |
id |
IMT-1_967af10b26ffc33f9eb13fc848b2ec2e |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/28529 |
network_acronym_str |
IMT-1 |
network_name_str |
Revista do Instituto de Medicina Tropical de São Paulo |
repository_id_str |
|
spelling |
Intrathecal antitoxin in the treatment of tetanus Soroterapia intratecal no tétano. Revisão Tétano^i1^sterapêutAntitoxina tetânica^i1^sAdministração intrateUso terapêutico^i1^sAdministração e dosa Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit. Devido à importância do tétano nos países em desenvolvimento, foi feita uma revisão da literatura recente abordando aspectos históricos e bases fisio-patológicas do uso da soroterapia intratecal no tratamento do tétano. Discute-se principalmente a eficácia dessa terapêutica envolvendo o uso da antitoxina heteróloga e homóloga, associada ou não à antitoxina e a corticosteróides por via sistêmica. São abordadas também as complicações do uso da antitoxina por via intrarraquideana que são, em geral, leves e transitórias. As tentativas de introduzir definitivamente a administração intratecal da antitoxina tetânica, na terapêutica do tétano, são precoces, uma vez que estudos existentes até o momento tem resultados contraditórios e muitas variáveis envolvidas. Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo1987-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rimtsp/article/view/28529Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 5 (1987); 255-267 1678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTporhttps://www.revistas.usp.br/rimtsp/article/view/28529/30382Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessLevin, Anna Sara ShaffermanBarone, Antonio AlciShiroma, Mario2012-07-02T00:57:49Zoai:revistas.usp.br:article/28529Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:50:15.666108Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true |
dc.title.none.fl_str_mv |
Intrathecal antitoxin in the treatment of tetanus Soroterapia intratecal no tétano. Revisão |
title |
Intrathecal antitoxin in the treatment of tetanus |
spellingShingle |
Intrathecal antitoxin in the treatment of tetanus Levin, Anna Sara Shafferman Tétano^i1^sterapêut Antitoxina tetânica^i1^sAdministração intrate Uso terapêutico^i1^sAdministração e dosa |
title_short |
Intrathecal antitoxin in the treatment of tetanus |
title_full |
Intrathecal antitoxin in the treatment of tetanus |
title_fullStr |
Intrathecal antitoxin in the treatment of tetanus |
title_full_unstemmed |
Intrathecal antitoxin in the treatment of tetanus |
title_sort |
Intrathecal antitoxin in the treatment of tetanus |
author |
Levin, Anna Sara Shafferman |
author_facet |
Levin, Anna Sara Shafferman Barone, Antonio Alci Shiroma, Mario |
author_role |
author |
author2 |
Barone, Antonio Alci Shiroma, Mario |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Levin, Anna Sara Shafferman Barone, Antonio Alci Shiroma, Mario |
dc.subject.por.fl_str_mv |
Tétano^i1^sterapêut Antitoxina tetânica^i1^sAdministração intrate Uso terapêutico^i1^sAdministração e dosa |
topic |
Tétano^i1^sterapêut Antitoxina tetânica^i1^sAdministração intrate Uso terapêutico^i1^sAdministração e dosa |
description |
Tetanus is an important disease in underdeveloped countries. We present a review of literature concerning the use of intrathecal antitoxin in the treatment of tetanus. Historical aspects and the physiopathologic basis for this route of administration of antitoxin are brought up and the efficacy of the uses of heterologous and homologous antitoxin associated or not to systemic antitoxin and steroids is discussed. A great number of clinical studies have been done and many aren't well controlled or conclusive. Others have conflicting results. Homologous antitoxin (TIG) was used by GUPTA 14, in slight cases of tetanus; DIOP-MAR et al5, in Senegal; and LIST22, in Austria, with a reduction of the mortality by the disease when of its intrathecal use. However, BOLOT et al34, in France; SEDAGHATIAN35, and VALKI et al 44,45,46, don't obtain favorable results with intrathecal TIG. The same controversy arises with the use of intrathecal heterologous antitoxin (SAT). GALLAIS et al 10,11,12; SINGH et al38; KESWANI et al21; SANDERS et al32, obtain significantly better results when compared to their control groups, NEEQUAYE et al23; THOMAS et al43; and BHANDARI et al², find no advantages to the use of this route. There are a number of factors possibly responsible for these differences in results: the intrathecal or systemic use of steroids; the use of homologous or heterologous antitoxin; their dosage and route of administration. The adverse effects due to intrathecal antitoxin are in general slight, however this route of administration should be considered experimental until there is further evidence of its benefit. |
publishDate |
1987 |
dc.date.none.fl_str_mv |
1987-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/28529 |
url |
https://www.revistas.usp.br/rimtsp/article/view/28529 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rimtsp/article/view/28529/30382 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Revista do Instituto de Medicina Tropical de São Paulo |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
publisher.none.fl_str_mv |
Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo |
dc.source.none.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 No. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; Vol. 29 Núm. 5 (1987); 255-267 Revista do Instituto de Medicina Tropical de São Paulo; v. 29 n. 5 (1987); 255-267 1678-9946 0036-4665 reponame:Revista do Instituto de Medicina Tropical de São Paulo instname:Instituto de Medicina Tropical (IMT) instacron:IMT |
instname_str |
Instituto de Medicina Tropical (IMT) |
instacron_str |
IMT |
institution |
IMT |
reponame_str |
Revista do Instituto de Medicina Tropical de São Paulo |
collection |
Revista do Instituto de Medicina Tropical de São Paulo |
repository.name.fl_str_mv |
Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT) |
repository.mail.fl_str_mv |
||revimtsp@usp.br |
_version_ |
1798951637215084544 |